Glucokinase (GCK) serves as the pancreatic glucose sensor. Heterozygous inactivating GCK mutations cause hyperglycemia, whereas activating mutations cause hypoglycemia. We studied the GCK V62M mutation identified in two families and co-segregating with hyperglycemia to understand how this mutation resulted in reduced function. Structural modeling locates the mutation close to five naturally occurring activating mutations in the allosteric activator site of the enzyme. Recombinant glutathionyl S-transferase-V62M GCK is paradoxically activated rather than inactivated due to a decreased S0.5 for glucose compared with wild type (4.88 versus 7.55 mM). The recently described pharmacological activator (RO0281675) interacts with GCK at this site. V62M GCK does not respond to RO0281675, nor does it respond to the hepatic glucokinase regulatory protein (GKRP). The enzyme is also thermally unstable, but this lability is apparently less pronounced than in the proven instability mutant E300K. Functional and structural analysis of seven amino acid substitutions at residue Val62 has identified a non-linear relationship between activation by the pharmacological activator and the van der Waals interactions energies. Smaller energies allow a hydrophobic interaction between the activator and glucokinase, whereas larger energies prohibit the ligand from fitting into the binding pocket. We conclude that V62M may cause hyperglycemia by a complex defect of GCK regulation involving instability in combination with loss of control by a putative endogenous activator and/or GKRP. This study illustrates that mutations that cause hyperglycemia are not necessarily kinetically inactivating but may exert their effects by other complex mechanisms. Elucidating such mechanisms leads to a deeper understanding of the GCK glucose sensor and the biochemistry of beta-cells and hepatocytes.
Alvarez Elvira, Roncero Isabel, Chowen Julie A., Vazquez Patricia, Blazquez Enrique, Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain, 10.1046/j.0022-3042.2001.00677.x
Rizzo Mark A., Magnuson Mark A., Drain Peter F., Piston David W., A Functional Link between Glucokinase Binding to Insulin Granules and Conformational Alterations in Response to Glucose and Insulin, 10.1074/jbc.m112478200
Arden C., Harbottle A., Baltrusch S., Tiedge M., Agius L., Glucokinase Is an Integral Component of the Insulin Granules in Glucose-Responsive Insulin Secretory Cells and Does Not Translocate During Glucose Stimulation, 10.2337/diabetes.53.9.2346
Hattersley A.T, Turner R.C, Patel P, O'Rahilly S, Hattersley A.T, Patel P, Wainscoat J.S, Permutt M.A, Tanazawa Y, Chin K.C, Watkins P, Linkage of type 2 diabetes to the glucokinase gene, 10.1016/0140-6736(92)91958-b
Froguel Ph., Vaxillaire M., Sun F., Velho G., Zouali H., Butel M. O., Lesage S., Vionnet N., Clément K., Fougerousse F., Tanizawa Y., Weissenbach J., Beckmann J. S., Lathrop G. M., Passa Ph., Permutt M. A., Cohen D., Close linkage of glucokinase locus on chromosome 7p to early-onset
non-insulin-dependent diabetes mellitus, 10.1038/356162a0
Gloyn Anna L., Glucokinase (GCK) mutations in hyper- and hypoglycemia: Maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy, 10.1002/humu.10277
Gloyn A.L., Odili S., Buettger C., Njolstad P.R., Shiota C., Magnuson M.A., Matschinsky F.M., Glucokinase and the Regulation of Blood Sugar, Frontiers in Diabetes (2004) ISBN:3805577443 p.92-109, 10.1159/000079009
Davis E. A., Cuesta-Muñoz A., Raoul M., Buettger C., Sweet I., Moates M., Magnuson M. A., Matschinsky F. M., Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis, 10.1007/s001250051289
Miller S. P., Anand G. R., Karschnia E. J., Bell G. I., LaPorte D. C., Lange A. J., Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype, 10.2337/diabetes.48.8.1645
Matschinsky F. M., Regulation of Pancreatic -Cell Glucokinase: From Basics to Therapeutics, 10.2337/diabetes.51.2007.s394
J. Biol. Chem., 269, 3641 (1994)
BURKE Charlotte V., BUETTGER Carol W., DAVIS Elizabeth A., MCCLANE Steven J., MATSCHINSKY Franz M., RAPER Steven E., Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI), 10.1042/bj3420345
Gloyn A. L., Noordam K., Willemsen M. A.A.P., Ellard S., Lam W. W.K., Campbell I. W., Midgley P., Shiota C., Buettger C., Magnuson M. A., Matschinsky F. M., Hattersley A. T., Insights Into the Biochemical and Genetic Basis of Glucokinase Activation From Naturally Occurring Hypoglycemia Mutations, 10.2337/diabetes.52.9.2433
Glaser Benjamin, Kesavan Prebakaran, Heyman Mozhgan, Davis Elizabeth, Cuesta Antonio, Buchs Andreas, Stanley Charles A., Thornton Paul S., Permutt M. Alan, Matschinsky Franz M., Herold Kevan C., Familial Hyperinsulinism Caused by an Activating Glucokinase Mutation, 10.1056/nejm199801223380404
Cuesta-Munoz A. L., Huopio H., Otonkoski T., Gomez-Zumaquero J. M., Nanto-Salonen K., Rahier J., Lopez-Enriquez S., Garcia-Gimeno M. A., Sanz P., Soriguer F. C., Laakso M., Severe Persistent Hyperinsulinemic Hypoglycemia due to a De Novo Glucokinase Mutation, 10.2337/diabetes.53.8.2164
Christesen H. B.T., Jacobsen B. B., Odili S., Buettger C., Cuesta-Munoz A., Hansen T., Brusgaard K., Massa O., Magnuson M. A., Shiota C., Matschinsky F. M., Barbetti F., The Second Activating Glucokinase Mutation (A456V): Implications for Glucose Homeostasis and Diabetes Therapy, 10.2337/diabetes.51.4.1240
Mahalingam B., Cuesta-Munoz A., Davis E. A., Matschinsky F. M., Harrison R. W., Weber I. T., Structural model of human glucokinase in complex with glucose and ATP: implications for the mutants that cause hypo- and hyperglycemia, 10.2337/diabetes.48.9.1698
Grimsby J., Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy, 10.1126/science.1084073
Kamata Kenji, Mitsuya Morihiro, Nishimura Teruyuki, Eiki Jun-ichi, Nagata Yasufumi, Structural Basis for Allosteric Regulation of the Monomeric Allosteric Enzyme Human Glucokinase, 10.1016/j.str.2004.02.005
Brocklehurst K. J., Payne V. A., Davies R. A., Carroll D., Vertigan H. L., Wightman H. J., Aiston S., Waddell I. D., Leighton B., Coghlan M. P., Agius L., Stimulation of Hepatocyte Glucose Metabolism by Novel Small Molecule Glucokinase Activators, 10.2337/diabetes.53.3.535
Stoffel M., Froguel P., Takeda J., Zouali H., Vionnet N., Nishi S., Weber I. T., Harrison R. W., Pilkis S. J., Lesage S., Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus., 10.1073/pnas.89.16.7698
Liang Y, Kesavan P, Wang L Q, Niswender K, Tanizawa Y, Permutt M A, Magnuson M A, Matschinsky F M, Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme, 10.1042/bj3090167
Schuit F. C., Huypens P., Heimberg H., Pipeleers D. G., Glucose Sensing in Pancreatic -Cells: A Model for the Study of Other Glucose-Regulated Cells in Gut, Pancreas, and Hypothalamus, 10.2337/diabetes.50.1.1
Veiga-da-Cunha M., Xu L. Z., Lee Y. H., Marotta D., Pilkis S. J., Van Schaftingen E., Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein, 10.1007/bf02658503
KESAVAN Prabakaran, WANG Liqun, DAVIS Elizabeth, CUESTA Antonio, SWEET Ian, NISWENDER Kevin, MAGNUSON Mark A., MATSCHINSKY Franz M., Structural instability of mutant β-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2), 10.1042/bj3220057
Meglasson Martin D., Matschinsky Franz M., Pancreatic islet glucose metabolism and regulation of insulin secretion, 10.1002/dmr.5610020301
Stride A., Vaxillaire M., Tuomi T., Barbetti F., Njølstad P. R., Hansen T., Costa A., Conget I., Pedersen O., Søvik O., Lorini R., Groop L., Froguel P., Hattersley A. T., The genetic abnormality in the beta cell determines the response to an oral glucose load, 10.1007/s00125-001-0770-9
Veiga-da-Cunha Maria, Courtois Stephane, Michel Alain, Gosselain Eric, Van Schaftingen Emile, Amino Acid Conservation in Animal Glucokinases : IDENTIFICATION OF RESIDUES IMPLICATED IN THE INTERACTION WITH THE REGULATORY PROTEIN, 10.1074/jbc.271.11.6292
VANDERCAMMEN Annick, SCHAFTINGEN Emile, Competitive inhibition of liver glucokinase by its regulatory protein, 10.1111/j.1432-1033.1991.tb16217.x
Veiga-da-Cunha M., Delplanque J., Gillain A., Bonthron D. T., Boutin P., Van Schaftingen E., Froguel P., Mutations in the glucokinase regulatory protein gene in 2p23 in obese French caucasians, 10.1007/s00125-003-1083-y
Moukil M. A., Veiga-da-Cunha M., Van Schaftingen E., Study of the regulatory properties of glucokinase by site-directed mutagenesis: conversion of glucokinase to an enzyme with high affinity for glucose, 10.2337/diabetes.49.2.195
Baltrusch Simone, Lenzen Sigurd, Okar David A., Lange Alex J., Tiedge Markus, Characterization of Glucokinase-binding Protein Epitopes by a Phage-displayed Peptide Library : IDENTIFICATION OF 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE AS A NOVEL INTERACTION PARTNER, 10.1074/jbc.m105470200
SCHAFTINGEN Emile, A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate, 10.1111/j.1432-1033.1989.tb14538.x
Muñoz-Alonso Maria J., Guillemain Ghislaine, Kassis Nadim, Girard Jean, Burnol Anne-Françoise, Leturque Armelle, A Novel Cytosolic Dual Specificity Phosphatase, Interacting with Glucokinase, Increases Glucose Phosphorylation Rate, 10.1074/jbc.m000841200
Njølstad PR, Cockburn BN, Bell GI, Søvik O., A missense mutation, Val62Ala, in the glucokinase gene in a Norwegian family with maturity-onset diabetes of the young, 10.1080/080352598750013626
Corbett, W. L., Crowther, R. L., Dunten, P. W., Kammlott, R. U., and Lukacs, C. M. (August 20, 2003) Crystal Structure Patent GB2385328
FASEB J., 8, 414 (1994)
Toyoda Y., Tsuchida A., Iwami E., Shironoguchi H., Miwa I., Regulation of Hepatic Glucose Metabolism by Translocation of Glucokinase between the Nucleus and the Cytoplasm in Hepatocytes, 10.1055/s-2001-15418
Postic Catherine, Shiota Masakazu, Niswender Kevin D., Jetton Thomas L., Chen Yeujin, Moates J. Michael, Shelton Kathy D., Lindner Jill, Cherrington Alan D., Magnuson Mark A., Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase, 10.1074/jbc.274.1.305
Grimsby Joseph, Coffey John W., Dvorozniak Mark T., Magram Jeanne, Li Guizhu, Matschinsky Franz M., Shiota Chiyo, Kaur Satbir, Magnuson Mark A., Grippo Joseph F., Characterization of Glucokinase Regulatory Protein-deficient Mice, 10.1074/jbc.275.11.7826
J. Biol. Chem., 252, 8519 (1977)
Bibliographic reference
Gloyn, Anna L ; Odili, Stella ; Zelent, Dorothy ; Buettger, Carol ; Castleden, Harriet A J ; et. al. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.. In: The Journal of biological chemistry, Vol. 280, no. 14, p. 14105-13 (2005)